Literature DB >> 12654381

Progressive outer retinal necrosis in immunocompetent patients treated initially for optic neuropathy with systemic corticosteroids.

Matthew S Benz1, Joel S Glaser, Janet L Davis.   

Abstract

PURPOSE: To report two cases of progressive outer retinal necrosis occurring in immunocompetent individuals after treatment with corticosteroids for presumed optic neuropathy.
DESIGN: Observational case report.
SETTING: University-based tertiary eye hospital.
METHODS: Retrospective review of existing clinical records.
RESULTS: Two patients were treated empirically with systemic corticosteroids for suspected inflammatory papillopathy. Subsequently, both were diagnosed with necrotizing herpetic retinitis with features of progressive outer retinal necrosis. Anterior chamber paracentesis confirmed varicella-zoster infection. Both patients were human immunodeficiency virus negative; one patient with rheumatoid arthritis was taking etanercept. Both became completely blind in one eye despite intensive treatment with antiviral medication intravenously and intravitreally.
CONCLUSIONS: Progressive outer retinal necrosis is not confined to patients with underlying severe immunodeficiency, such as acquired immune deficiency syndrome. Initial treatment of acute, unexplained vision loss with systemic corticosteroids may lead to catastrophic visual loss in patients with evolving necrotizing herpetic retinopathy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12654381     DOI: 10.1016/s0002-9394(02)01978-5

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  10 in total

Review 1.  Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety.

Authors:  K L Hyrich; A J Silman; K D Watson; D P M Symmons
Journal:  Ann Rheum Dis       Date:  2004-07-08       Impact factor: 19.103

2.  An unusual cause for an optic disc haemorrhage.

Authors:  Julia Baxter; Anusha Kailasanathan; Hean Chen
Journal:  BMJ Case Rep       Date:  2011-02-14

3.  Acute retinal necrosis in multiple sclerosis: A neuroimmunologic challenge!

Authors:  Zubeda Sheikh; Shashank Jain; Machteld Hillen
Journal:  Neurology       Date:  2016-01-29       Impact factor: 9.910

4.  Viral retinitis after intravitreal triamcinolone injection in patients with predisposing medical comorbidities.

Authors:  Ankur M Shah; Stephen F Oster; William R Freeman
Journal:  Am J Ophthalmol       Date:  2010-03       Impact factor: 5.258

5.  Fundus Autofluorescence and OCT in the Management of Progressive Outer Retinal Necrosis.

Authors:  Steven Yeh; Wai T Wong; Eric D Weichel; Julie C Lew; Emily Y Chew; Robert B Nussenblatt
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2010-03-09

6.  Varicella zoster virus acute retinal necrosis following eye contusion: case report.

Authors:  Petra Svozílková; Eva Ríhová; Pavel Diblík; Pavel Kuthan; Zdenek Kovarík; Bohdana Kalvodová
Journal:  Virol J       Date:  2005-08-31       Impact factor: 4.099

7.  Progressive outer retinal necrosis and immunosuppressive therapy in myasthenia gravis.

Authors:  Solène Coisy; Jean-Marc Ebran; Dan Milea
Journal:  Case Rep Ophthalmol       Date:  2014-04-22

8.  Optic disc edema with peripapillary serous retinal detachment as the presenting sign of necrotizing herpetic retinitis.

Authors:  Caleb C Ng; H Richard McDonald; Robert N Johnson; Emmett T Cunningham
Journal:  Am J Ophthalmol Case Rep       Date:  2022-02-11

Review 9.  Immunomodulatory Effects of Hydroxychloroquine and Chloroquine in Viral Infections and Their Potential Application in Retinal Gene Therapy.

Authors:  Laurel C Chandler; Imran H Yusuf; Michelle E McClements; Alun R Barnard; Robert E MacLaren; Kanmin Xue
Journal:  Int J Mol Sci       Date:  2020-07-14       Impact factor: 5.923

10.  Case series: Two cases of herpetic retinitis presenting as progressive outer retinal necrosis in immunocompetent individuals.

Authors:  Heather V Broyles; Joseph W Fong; Ahmed B Sallam
Journal:  Am J Ophthalmol Case Rep       Date:  2021-06-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.